Skip to content

Survodutide: Dosage & Administration

Part of the Survodutide Complete Guide

Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

We may earn a commission if you purchase through this link, at no extra cost to you.

Dosage Protocols

IndicationDose RangeRouteFrequency
Obesity (Phase 2)0.3–6 mgSC injectionWeekly
MASH (Phase 2)2.4–6 mgSC injectionWeekly

Dose escalation over several weeks to target dose. The 4.8 mg dose showed the best balance of efficacy and tolerability in Phase 2 MASH trials.

Administration

Clinical trial formulations are pre-filled. Not available as a research compound. Subcutaneous injection administration.

Timing

Weekly injection. Phase 2 MASH trial duration was 48 weeks. Long-term use anticipated.

Storage

  • Clinical formulations: refrigerate at 2–8°C
  • Do not freeze

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

Related Guides

PI

Peptides Insider Editorial Team

Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.